Veris Residential Files Rule 144 Notice After Multi-Million Affiliated Sales

Rhea-AI Filing Summary

Veris Residential, Inc. (VRE) filed a Form 144 reporting proposed sales of common stock through Morgan Stanley Smith Barney on the NYSE. The notice lists 40,355 shares planned for sale with an aggregate market value of $622,601.55 against 93,421,769 shares outstanding, with an approximate sale date of 09/16/2025. The filing discloses prior open-market acquisitions of the reported shares in July 2018, paid in cash, and shows multiple recent sales by affiliated entities between 09/09/2025 and 09/15/2025 totaling substantial share volumes and gross proceeds in the millions. The filer certifies no undisclosed material adverse information and includes standard Rule 144 representations.

Positive

• Transparency: The filing specifies broker, share count, acquisition dates, and aggregate market value in accordance with Rule 144.
• Disclosure of recent sales: Multiple recent sales by affiliated entities are listed with dates and gross proceeds, providing visibility into recent dispositions.

Negative

• Limited context: The filing does not state remaining beneficial ownership after sales or whether trades occur under a Rule 10b5-1 plan.
• Potential insider liquidity: Significant affiliated sales in the prior week totaling multi-million-dollar proceeds may signal concentrated selling pressure without explanation.

Insights

Securities Analyst

TL;DR: A planned authenticated sale of 40,355 VRE shares follows substantial affiliated selling over a one-week span, indicating notable insider liquidity.

The filing documents a Rule 144 notice for 40,355 common shares valued at $622,602 to be sold via Morgan Stanley on the NYSE, with the shares originally purchased in July 2018. Recent aggregated sales by related entities between 09/09/2025 and 09/15/2025 show large volumes and multi-million-dollar proceeds, suggesting coordinated or staggered dispositions by affiliated sellers. For investors, the filing provides clear disclosure of sale mechanics but does not include motives, holdings post-sale, or impact on control. Materiality hinges on relative volume versus free float and context from recent trading; those data are not included here.

Corporate Governance Expert

TL;DR: Formal Rule 144 notice meets disclosure standards but lacks contextual details on insider status and any trading plans.

The submission complies with Rule 144 requirements by identifying the broker, share counts, acquisition dates, and recent affiliated sales. It includes the required representation that the seller has no undisclosed material information. However, the filing does not state whether sales follow a written trading plan (Rule 10b5-1) or the remaining beneficial ownership after these transactions, limiting assessment of governance implications. Absent those details, the filing is procedurally complete but leaves open questions about timing and coordination of disposals.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	40355	622601.55	93421769	09/16/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/25/2018	Open Market Purchase	Open Market			30404	07/27/2018	Cash
Common	07/24/2018	Open Market Purchase	Open Market			9951	07/26/2018	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/15/2025	19838	310454.78
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/15/2025	26600	416276.70
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/12/2025	79724	1272734.52
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/12/2025	106897	1706531.26
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/11/2025	114560	1840956.29
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/11/2025	85440	1373003.71
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/10/2025	85920	1378491.89
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/10/2025	64080	1028093.11
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/09/2025	64080	1032924.74
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/09/2025	85920	1384970.29

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for VRE report?

The Form 144 reports a proposed sale of 40,355 common shares via Morgan Stanley on the NYSE with an aggregate market value of $622,601.55 and lists related prior sales.

Who is the broker handling the VRE proposed sale?

The broker named is Morgan Stanley Smith Barney LLC, Executive Financial Services located in New York.

When were the shares being sold originally acquired?

The shares reported for sale were acquired in open-market purchases on 07/24/2018 and 07/25/2018, paid in cash.

Did the filing disclose recent related-party sales of VRE stock?

Yes. The filing lists multiple sales by affiliated entities from 09/09/2025 through 09/15/2025 with volumes and gross proceeds totaling several million dollars.

Does the Form 144 state whether a trading plan was used?

No. The filing does not indicate adoption of a Rule 10b5-1 trading plan or provide the seller's post-sale ownership level.